EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY 4.0

Observational Study on Subcutaneous Immunotherapy for Japanese Cedar Pollinosis in 2024: Comparison With 2019

Otsuka Hirokuni iD, Okubo Kimihiro, Otsuka Kuninori, Gotoh Minoru iD

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70589 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 13.11.2026. Verfasst von Otsuka Hirokuni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Otsuka ENT Clinic, Otorhinolaryngology, Kanagawa, Japan. Hauptthemen laut MEDLINE: Rhinitis, Allergic, Seasonal, Cryptomeria, Desensitization, Immunologic, Pollen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective In a 2019 observational cohort study, we showed that subcutaneous allergen immunotherapy (SCIT) reduced symptoms in the preseason and during the Japanese cedar pollinosis (JCP) season. SCIT reduced metachromatic cells (Mc) and eosinophils in nasal swabs in subjects with JCP. The current 2024 study is compared with our 2019 study, focusing on the two JCP seasons to determine whether SCIT could further reduce symptoms and the counts of these cells in nasal swabs, particularly in patients who had received SCIT for ≥ 5 years.

Methods

Thirty‐three subjects with SCIT treatment for JCP and 53 subjects without SCIT in the 2019 season, and 30 subjects with SCIT treatment and 40 subjects without SCIT in the 2024 season, were interviewed in season in both years, and Mc and eosinophil counts were examined in nasal swabs.

Results

In 2019, there was a significant difference between the 33 subject visits with SCIT and the 53 subjects without SCIT: p = 2.2 × 10 −5 for severity, p = 0.002 for Mc counts in nasal swabs, and p = 0.008 for eosinophil counts. In 2024, there was a significant difference between the 30 subject visits with SCIT and the 40 subjects without SCIT: p = 2.4 × 10 −8 for severity, p = 2.6 × 10 −6 for Mc counts in nasal swabs, and p = 2.7 × 10 −8 for eosinophil counts. The 13 cases investigated in both 2019 and 2024 that had been on SCIT continuously showed significantly improved outcomes in 2024, in comparison to those on shorter‐duration SCIT treatment.

Conclusion

SCIT can be safely administered at the doses described below, and a 2024 study showed not only symptom relief but also a dramatic reduction in Mc and eosinophil counts in nasal swabs compared to a 2019 study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhinitis, Allergic, SeasonalCryptomeriaDesensitization, ImmunologicPollenAllergensHumansFemaleMaleAdultEosinophilsInjections, SubcutaneousMiddle AgedTreatment OutcomeYoung AdultJapan

Stichwörter der Autor:innen

Japanese cedar pollinosiseosinophilmast cellmetachromatic cellnasal surfacenasal swabsneutrophilobservational cohortssubcutaneous immunotherapysublingual immunotherapy

Substanzen

Allergens

Autor:innen und Institutionen

  • Otsuka ENT Clinic, Otorhinolaryngology, Kanagawa, Japan.
  • Musashikosugi Hospital, Otorhinolaryngology, Nippon Medical School, Kanagawa, Japan.
  • Otorhinolaryngology and Head and Neck Surgery, Nippon Medical School, Kanagawa, Japan.

ORCID-Profile: Otsuka Hirokuni, Gotoh Minoru

Zitieren

APA

Hirokuni, O., Kimihiro, O., Kuninori, O., & Minoru, G. (2026). Observational Study on Subcutaneous Immunotherapy for Japanese Cedar Pollinosis in 2024: Comparison With 2019. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70589

Vancouver

Hirokuni O, Kimihiro O, Kuninori O, Minoru G. Observational Study on Subcutaneous Immunotherapy for Japanese Cedar Pollinosis in 2024: Comparison With 2019. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70589

BibTeX
@article{Hirokuni2026,
  author = {Hirokuni, Otsuka and Kimihiro, Okubo and Kuninori, Otsuka and Minoru, Gotoh},
  title = {Observational Study on Subcutaneous Immunotherapy for Japanese Cedar Pollinosis in 2024: Comparison With 2019},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1002/iid3.70589}
}
Kostenlos starten →